Robert Sarrazin is Chief Investment Officer and Managing Partner at the Autism Impact Fund, overseeing its Life Sciences practice. He previously held roles at GlaxoSmithKline, CSW, and Charter Oak Partners, and earned degrees from Richard Ivey Business School and Leonard N. Stern School of Business.
At firms with a similar stage, sector and check size.



One email when Robert's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRobert Sarrazin is Chief Investment Officer and Managing Partner at the Autism Impact Fund, overseeing its Life Sciences practice. He previously held roles at GlaxoSmithKline, CSW, and Charter Oak Partners, and earned degrees from Richard Ivey Business School and Leonard N. Stern School of Business.
Autism Impact Fund has not reported a check size. It invests at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Robert in the subject. A warm intro from a founder Autism Impact Fund backed works better.
private equity division at Charter Oak Partners; Senior Partner at CSW.
Last updated 2026-10-15. Is this you? Ask for a correction.